Skip to main content

Advertisement

Fig. 2 | Trials

Fig. 2

From: An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India

Fig. 2

The percentage of trials with errors, in four 3-year time periods, for the several categories of errors. a Error rates (1) for Type of Study: Large number of categories (although this is not strictly an “error rate”, we have labeled it as such since all other problems reported here are error rates); (2) in determining the unambiguously Indian trials; (3) in determining the unambiguously Multinational trials; (4) for Indian trials: Interventional cases with Phase listed as PMS; (5) for Indian trials: More ethics committees than trial sites; and (6) for Multinational trials: More ethics committees than trial sites. b Error rates for the (1) redefined Indian trials: Type of Trial was PMS, but Phase of Trial was Phase 4; (2) redefined Indian trials: Type of Trial was BA/BE, but Phase of trial was 1, 1/2, 2, 2/3, 3, 3/4, or 4; (3) Indian trials: incorrect listing of cities; and (4) Multinational trials: incorrect listing of cities. c Error rates for the (1) Indian trials: PI names listed as nil; (2) Multinational trials: PI names listed as nil; (3) redefined Indian trials: Type of Study was NA, but Phase of trial was 1, 1/2, 2, 2/3, 3, 3/4, or 4; (4) Indian trials: Primary Sponsor name nil; (5) Indian trials: state of trial site missing; and (6) Multinational trials: state of trial site missing

Back to article page